VE1 (BRAF V600E) immunohistochemistry in colorectal cancer: Validation, assessment of heterogeneity and clinicopathological associations in three colorectal cancer cohorts

被引：0
|
作者：
Schafroth, C. [1 ]
Galvan, J. A. [1 ]
Sokol, L. [1 ]
Rieger, G. [1 ]
Dawson, H. E. [1 ]
Koelzer, V. H. [1 ]
Langer, R. [1 ]
Lugli, A. [1 ]
Zlobec, I. [1 ]
机构：
[1] Univ Bern, Inst Pathol, CH-3012 Bern, Switzerland
来源：
VIRCHOWS ARCHIV | 2015年 / 467卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-16-001
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Analysis of BRAF V600E (VE1) protein expression and BRAF mutation status in salivary gland cancers
    Bodnar, M.
    Burduk, P.
    Szczodruch, P.
    Jarmuz-Szymczak, M.
    Giefing, M.
    Wierzbicka, M.
    Marszalek, A.
    VIRCHOWS ARCHIV, 2016, 469 : S125 - S125
  • [42] Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment
    Liu, Mengling
    Liu, Qing
    Hu, Keshu
    Dong, Yu
    Sun, Xun
    Zou, Zhiguo
    Ji, Dingkun
    Liu, Tianshu
    Yu, Yiyi
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 204
  • [43] Colorectal Cancer with the BRAF V600E Mutation: Two Case Reports and Literature Review
    Pham, Nguyen Cuong
    Ho, Van Linh
    Ton-Nu, Victoria
    Ngo, Minh Tri
    Nguyen, Huu Son
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (03)
  • [44] Retrospective analysis of management of BRAF V600E mutated colorectal cancer in a single institution
    Perez Velasco, R.
    Macias Rodriguez, P.
    Garcia Grove, C.
    Martin Sanchez, D.
    Torrado, C.
    Barroso, A.
    Tallafigo, F.
    Monescillo, E.
    Buezas Perez, R.
    Torres Sempere, J.
    Pereira Vicente, A.
    Valladares-Ayerbes, M.
    Lopez Ladron, A.
    Rodriguez, J.
    Limon, L.
    Gallego Jimenez, I.
    ANNALS OF ONCOLOGY, 2023, 34 : S64 - S64
  • [45] Antitumor activity of panRAF inhibition in BRAF V600E metastatic colorectal cancer.
    Sorokin, Alex
    Bitner, Lea
    Wu, Ji
    Menter, David
    Kopetz, Scott
    Morris, Van Karlyle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] BRAF V600E mutated metastatic colorectal cancer: current progress and future directions
    Kam, Audrey E.
    Eng, Cathy
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (10) : 1311 - 1313
  • [47] Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer
    Tak, Eunyoung
    An, Hye-In
    Lee, Amy Sinyoung
    Han, Kyuyoung
    Choi, Jiwan
    Kim, Hyung-don
    Hong, Yong Sang
    Kim, Sun Young
    Choi, Eun Kyung
    Kim, Jeong Eun
    Kim, Tae Won
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (05)
  • [48] Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis
    Kyle G. Parker
    Michael G. White
    Nicole A. Cipriani
    Head and Neck Pathology, 2020, 14 : 1067 - 1079
  • [49] Detection of the BRAF V600E mutation in colon cancer and thyroid cancer by immunohistochemistry.
    Dvorak, Katerina
    Palting, John
    Waring, Paul M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [50] Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms
    Bodnar, Magdalena
    Burduk, Pawel
    Antosik, Paulina
    Jarmuz-Szymczak, Malgorzata
    Wierzbicka, Malgorzata
    Marszalek, Andrzej
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2017, 46 (05) : 340 - 345
12345